Hypoxia-Associated Alternative Splicing Signature in Lung Adenocarcinoma

References

• Siegel RL , MillerKD , JemalA. Cancer statistics, 2019. CA Cancer J. Clin.69(1), 7–34 (2019).
   PubMed Web of Science ®Google Scholar
• Chen Z , FillmoreCM , HammermanPS , KimCF , WongK-K. Non-small-cell lung cancers: a heterogeneous set of diseases. Nat. Rev. Cancer14(8), 535–546 (2014).
   PubMed Web of Science ®Google Scholar
• Bray F , FerlayJ , SoerjomataramI , SiegelRL , TorreLA , JemalA. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin.68(6), 394–424 (2018).
   PubMed Web of Science ®Google Scholar
• Miller KD , NogueiraL , MariottoABet al. Cancer treatment and survivorship statistics, 2019. CA Cancer J. Clin.69(5), 363–385 (2019).
   PubMed Web of Science ®Google Scholar
• Gray EP , TeareMD , StevensJ , ArcherR. Risk prediction models for lung cancer: a systematic review. Clin. Lung Cancer17(2), 95–106 (2016).
   PubMed Web of Science ®Google Scholar
• Mckeown SR . Defining normoxia, physoxia and hypoxia in tumours – implications for treatment response. Br. J. Radiol.87(1035), 20130676 (2014).
   PubMed Web of Science ®Google Scholar
• Bharti SK , KakkadS , DanhierPet al. Hypoxia patterns in primary and metastatic prostate cancer environments. Neoplasia21(2), 239–246 (2019).
   PubMed Web of Science ®Google Scholar
• Chiu DK , TseAP , XuIMet al. Hypoxia inducible factor HIF-1 promotes myeloid-derived suppressor cells accumulation through ENTPD2/CD39L1 in hepatocellular carcinoma. Nat. Commun.8(1), 517 (2017).
   PubMed Web of Science ®Google Scholar
• Salem A , AsselinMC , ReymenBet al. Targeting hypoxia to improve non-small-cell lung cancer outcome. J. Natl Cancer Inst.110(1) doi:10.1093/jnci/djx160 (2018).
   PubMedGoogle Scholar
• Wang Y , ShangW , NiuM , TianJ , XuK. Hypoxia-active nanoparticles used in tumor theranostic. Int. J. Nanomed.14, 3705–3722 (2019).
   PubMed Web of Science ®Google Scholar
• Climente-González H , Porta-PardoE , GodzikA , EyrasE. The functional impact of alternative splicing in cancer. Cell Rep.20(9), 2215–2226 (2017).
   PubMed Web of Science ®Google Scholar
• Jing X , YangF , ShaoCet al. Role of hypoxia in cancer therapy by regulating the tumor microenvironment. Mol. Cancer18(1), 157 (2019).
   PubMed Web of Science ®Google Scholar
• Yang Y , QuA , WuQet al. Prognostic value of a hypoxia-related microRNA signature in patients with colorectal cancer. Aging12(1), 35–52 (2020).
   PubMedGoogle Scholar
• Liu Y , WuJ , HuangWet al. Development and validation of a hypoxia-immune-based microenvironment gene signature for risk stratification in gastric cancer. J. Transl. Med.18(1), 201 (2020).
   PubMed Web of Science ®Google Scholar
• Zhang B , TangB , GaoJ , LiJ , KongL , QinL. A hypoxia-related signature for clinically predicting diagnosis, prognosis and immune microenvironment of hepatocellular carcinoma patients. J. Transl. Med.18(1), 342 (2020).
   PubMed Web of Science ®Google Scholar
• Farina AR , CappabiancaL , SebastianoM , ZelliV , GuadagniS , MackayAR. Hypoxia-induced alternative splicing: the 11th hallmark of cancer. J. Exp. Clin. Cancer Res.39(1), 110 (2020).
   PubMed Web of Science ®Google Scholar
• Bowler E , PorazinskiS , UzorSet al. Hypoxia leads to significant changes in alternative splicing and elevated expression of CLK splice factor kinases in PC3 prostate cancer cells. BMC Cancer18(1), 355 (2018).
   PubMedGoogle Scholar
• Hirschfeld M , ZurHausen A , BettendorfH , JägerM , StickelerE. Alternative splicing of Cyr61 is regulated by hypoxia and significantly changed in breast cancer. Cancer Res.69(5), 2082–2090 (2009).
   PubMed Web of Science ®Google Scholar
• Pan Q , ShaiO , LeeLJ , FreyBJ , BlencoweBJ. Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat. Genet.40(12), 1413–1415 (2008).
   PubMed Web of Science ®Google Scholar
• Lee SC , Abdel-WahabO. Therapeutic targeting of splicing in cancer. Nat. Med.22(9), 976–986 (2016).
   PubMed Web of Science ®Google Scholar
• Marzese DM , Manughian-PeterAO , OrozcoJIJ , HoonDSB. Alternative splicing and cancer metastasis: prognostic and therapeutic applications. Clin. Exp. Metastasis35(5), 393–402 (2018).
   PubMed Web of Science ®Google Scholar
• Wu F , ChenQ , LiuCet al. Profiles of prognostic alternative splicing signature in hepatocellular carcinoma. Cancer Med.9(6), 2171–2180 (2020).
   PubMed Web of Science ®Google Scholar
• Mao S , LiY , LuZet al. Survival-associated alternative splicing signatures in esophageal carcinoma. Carcinogenesis40(1), 121–130 (2019).
   PubMed Web of Science ®Google Scholar
• Song J , LiuYD , SuJ , YuanD , SunF , ZhuJ. Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma. J. Cell. Physiol.234(12), 22753–22764 (2019).
   PubMed Web of Science ®Google Scholar
• Huang R , LiaoX , LiQ. Identification and validation of potential prognostic gene biomarkers for predicting survival in patients with acute myeloid leukemia. Onco Targets Ther.10, 5243–5254 (2017).
   PubMed Web of Science ®Google Scholar
• Wang N , GuoH , DongZet al. Establishment and validation of a 7-microRNA prognostic signature for non-small cell lung cancer. Cancer Manag. Res.10, 3463–3471 (2018).
   PubMed Web of Science ®Google Scholar
• Jiang W , GuoQ , WangC , ZhuY. A nomogram based on 9-lncRNAs signature for improving prognostic prediction of clear cell renal cell carcinoma. Cancer Cell Int.19, 208 (2019).
   PubMed Web of Science ®Google Scholar
• Piva F , GiuliettiM , BuriniAB , PrincipatoG. SpliceAid 2: a database of human splicing factors expression data and RNA target motifs. Hum. Mutat.33(1), 81–85 (2012).
   PubMed Web of Science ®Google Scholar
• Zhang W , ShenY , FengG. Predicting the survival of patients with lung adenocarcinoma using a four-gene prognosis risk model. Oncology Lett.18(1), 535–544 (2019).
   PubMed Web of Science ®Google Scholar
• Wei W , LvY , GanZ , ZhangY , HanX , XuZ. Identification of key genes involved in the metastasis of clear cell renal cell carcinoma. Oncology Lett.17(5), 4321–4328 (2019).
   PubMed Web of Science ®Google Scholar
• Chakraborty H , HossainA. R package to estimate intracluster correlation coefficient with confidence interval for binary data. Comput. Methods Programs Biomed.155, 85–92 (2018).
   PubMed Web of Science ®Google Scholar
• Foroutan M , BhuvaDD , LyuR , HoranK , CursonsJ , DavisMJ. Single sample scoring of molecular phenotypes. BMC Bioinformatics19(1), 404 (2018).
   PubMed Web of Science ®Google Scholar
• Li H , TongL , TaoH , LiuZ. Genome-wide analysis of the hypoxia-related DNA methylation-driven genes in lung adenocarcinoma progression. Biosci. Rep.40(2), BSR20194200 (2020).
   PubMedGoogle Scholar
• Mayakonda A , LinDC , AssenovY , PlassC , KoefflerHP. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res.28(11), 1747–1756 (2018).
   PubMed Web of Science ®Google Scholar
• Yarchoan M , HopkinsA , JaffeeEM. Tumor mutational burden and response rate to PD-1 inhibition. N. Engl. J. Med.377(25), 2500–2501 (2017).
   PubMed Web of Science ®Google Scholar
• Samstein RM , LeeCH , ShoushtariANet al. Tumor mutational load predicts survival after immunotherapy across multiple cancer types. Nat. Genet.51(2), 202–206 (2019).
   PubMed Web of Science ®Google Scholar
• Schrock AB , OuyangC , SandhuJet al. Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer. Ann. Oncol.30(7), 1096–1103 (2019).
   PubMed Web of Science ®Google Scholar
• Carter BW , LichtenbergerJP3rd , BenvenisteMKet al. Revisions to the TNM staging of lung cancer: rationale, significance, and clinical application. Radiographics38(2), 374–391 (2018).
   PubMed Web of Science ®Google Scholar
• De Sousa VML , CarvalhoL. Heterogeneity in lung cancer. Pathobiology85(1-2), 96–107 (2018).
   PubMed Web of Science ®Google Scholar
• Dawood S , AustinL , CristofanilliM. Cancer stem cells: implications for cancer therapy. Oncology28(12), 1101–1107 (2014).
   PubMed Web of Science ®Google Scholar
• Hua X , ZhaoW , PesatoriACet al. Genetic and epigenetic intratumor heterogeneity impacts prognosis of lung adenocarcinoma. Nat. Commun.11(1), 2459 (2020).
   PubMed Web of Science ®Google Scholar
• Lim W , RidgeCA , NicholsonAG , MirsadraeeS. The 8th lung cancer TNM classification and clinical staging system: review of the changes and clinical implications. Quant. Imaging Med. Surg.8(7), 709–718 (2018).
   PubMed Web of Science ®Google Scholar
• Zhong J , RenX , ChenZet al. miR-21-5p promotes lung adenocarcinoma progression partially through targeting SET/TAF-Iα. Life Sci.231, 116539 (2019).
   PubMed Web of Science ®Google Scholar
• Dong HX , WangR , JinXY , ZengJ , PanJ. LncRNA DGCR5 promotes lung adenocarcinoma (LUAD) progression via inhibiting hsa-mir-22-3p. J. Cell. Physiol.233(5), 4126–4136 (2018).
   PubMed Web of Science ®Google Scholar
• Lu QC , RuiZH , GuoZL , XieW , ShanS , RenT. LncRNA-DANCR contributes to lung adenocarcinoma progression by sponging miR-496 to modulate mTOR expression. J. Cell. Mol. Med.22(3), 1527–1537 (2018).
   PubMed Web of Science ®Google Scholar
• Qiu M , XiaW , ChenRet al. The circular RNA circPRKCI promotes tumor growth in lung adenocarcinoma. Cancer Res.78(11), 2839–2851 (2018).
   PubMed Web of Science ®Google Scholar
• Zhang HM , YangB , ChenHFet al. Prognosis-related miRNA bioinformatics screening of lung adenocarcinoma and its clinical significance. Chin. J. Appl. Physiol.34(6), 530–535 (2018).
   Google Scholar
• Liang Y , SongJ , HeDet al. Systematic analysis of survival-associated alternative splicing signatures uncovers prognostic predictors for head and neck cancer. J. Cell. Physiol.234(9), 15836–15846 (2019).
   PubMed Web of Science ®Google Scholar
• Wu HY , PengZG , HeRQet al. Prognostic index of aberrant mRNA splicing profiling acts as a predictive indicator for hepatocellular carcinoma based on TCGA SpliceSeq data. Int. J. Oncol.55(2), 425–438 (2019).
   PubMed Web of Science ®Google Scholar
• Kanopka A . Cell survival: interplay between hypoxia and pre-mRNA splicing. Exp. Cell Res.356(2), 187–191 (2017).
   PubMed Web of Science ®Google Scholar
• Bates DO , CuiTG , DoughtyJMet al. VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma. Cancer Res.62(14), 4123–4131 (2002).
   PubMed Web of Science ®Google Scholar
• Makino Y , KanopkaA , WilsonWJ , TanakaH , PoellingerL. Inhibitory PAS domain protein (IPAS) is a hypoxia-inducible splicing variant of the hypoxia-inducible factor-3alpha locus. J. Biol. Chem.277(36), 32405–32408 (2002).
   PubMed Web of Science ®Google Scholar
• Peciuliene I , VilysL , JakubauskieneE , ZaliauskieneL , KanopkaA. Hypoxia alters splicing of the cancer associated Fas gene. Exp. Cell Res.380(1), 29–35 (2019).
   PubMed Web of Science ®Google Scholar
• Nakayama K , KataokaN. Regulation of gene expression under hypoxic conditions. Int. J. Mol. Sci.20(13), 3278 (2019).
   PubMed Web of Science ®Google Scholar
• Wang Y , PiaoJ , WangQet al. Paip1 predicts poor prognosis and promotes tumor progression through AKT/GSK-3β pathway in lung adenocarcinoma. Hum. Pathol.86, 233–242 (2019).
   PubMed Web of Science ®Google Scholar
• Fernandez P , CarreteroJ , MedinaPPet al. Distinctive gene expression of human lung adenocarcinomas carrying LKB1 mutations. Oncogene23(29), 5084–5091 (2004).
   PubMed Web of Science ®Google Scholar
• Huang H , LiT , ChenMet al. Identification and validation of NOLC1 as a potential target for enhancing sensitivity in multidrug resistant non-small-cell lung cancer cells. Cell. Mol. Biol. Lett.23, 54 (2018).
   PubMed Web of Science ®Google Scholar
• Zheng P , LiL. FANCI cooperates with IMPDH2 to promote lung adenocarcinoma tumor growth via a MEK/ERK/MMPs pathway. Onco Targets Ther.13, 451–463 (2020).
   PubMed Web of Science ®Google Scholar
• Li J , LiuL , LiuX , XuP , HuQ , YuY. The role of upregulated DDX11 as a potential prognostic and diagnostic biomarker in lung adenocarcinoma. J. Cancer10(18), 4208–4216 (2019).
   PubMed Web of Science ®Google Scholar
• Wu K , HuM , ChenZet al. Asiatic acid enhances survival of human AC16 cardiomyocytes under hypoxia by upregulating miR-1290. IUBMB Life69(9), 660–667 (2017).
   PubMed Web of Science ®Google Scholar
• Bonkowsky JL , SonJH. Hypoxia and connectivity in the developing vertebrate nervous system. Dis. Model. Mech.11(12), dmm037127 (2018).
   PubMed Web of Science ®Google Scholar
• Xu Z , LvH , WangYet al. HAND2-AS1 inhibits gastric adenocarcinoma cells proliferation and aerobic glycolysis via miRNAs sponge. Cancer Manag. Res.1(12), 3053–3068 (2020).
   Google Scholar
• Jyotsana N , HeuserM. Exploiting differential RNA splicing patterns: a potential new group of therapeutic targets in cancer. Expert Opin. Ther. Targets22(2), 107–121 (2018).
   PubMed Web of Science ®Google Scholar
• Bonomi S , GalloS , CatilloM , PignataroD , BiamontiG , GhignaC. Oncogenic alternative splicing switches: role in cancer progression and prospects for therapy. Int. J. Cell Biol.2013, 962038 (2013).
   PubMedGoogle Scholar
• Fan J , WangK , DuXet al. ALYREF links 3′-end processing to nuclear export of non-polyadenylated mRNAs. EMBO J.38(9), 2019).
   Web of Science ®Google Scholar
• Shi M , ZhangH , WuXet al. ALYREF mainly binds to the 5′ and the 3′ regions of the mRNA in vivo. Nucleic Acids Res.45(16), 9640–9653 (2017).
   PubMed Web of Science ®Google Scholar
• Ouyang D , YangP , CaiJ , SunS , WangZ. Comprehensive analysis of prognostic alternative splicing signature in cervical cancer. Cancer Cell Int.20, 221 (2020).
   PubMed Web of Science ®Google Scholar
• Dou N , YangD , YuS , WuB , GaoY , LiY. SNRPA enhances tumour cell growth in gastric cancer through modulating NGF expression. Cell Prolif.51(5), e12484 (2018).
   PubMed Web of Science ®Google Scholar
• Quidville V , AlsafadiS , GoubarAet al. Targeting the deregulated spliceosome core machinery in cancer cells triggers mTOR blockade and autophagy. Cancer Res.73(7), 2247–2258 (2013).
   PubMed Web of Science ®Google Scholar
• Sun C , WangG , WrightonKHet al. Regulation of p27(Kip1) phosphorylation and G1 cell cycle progression by protein phosphatase PPM1G. Am. J. Cancer Res.6(10), 2207–2220 (2016).
   PubMed Web of Science ®Google Scholar
• Yi M , LiT , QinSet al. Identifying tumorigenesis and prognosis-related genes of lung adenocarcinoma: based on weighted gene coexpression network analysis. Biomed. Res. Int.2020, 4169691 (2020).
   PubMed Web of Science ®Google Scholar
• Liu J , StevensPD , EshlemanNE , GaoT. Protein phosphatase PPM1G regulates protein translation and cell growth by dephosphorylating 4E binding protein 1 (4E-BP1). J. Biol. Chem.288(32), 23225–23233 (2013).
   PubMed Web of Science ®Google Scholar
• Kim YD , LeeJ , KimHSet al. The unique spliceosome signature of human pluripotent stem cells is mediated by SNRPA1, SNRPD1, and PNN. Stem Cell Res.22, 43–53 (2017).
   PubMed Web of Science ®Google Scholar
• Luo C , LeiM , ZhangYet al. Systematic construction and validation of an immune prognostic model for lung adenocarcinoma. J. Cell. Mol. Med.24(2), 1233–1244 (2020).
   PubMed Web of Science ®Google Scholar
• Noman MZ , HasmimM , MessaiYet al. Hypoxia: a key player in antitumor immune response. A review in the theme: cellular responses to hypoxia.. Am. J. Physiol. Cell Physiol.309(9),C569–C579 (2015).
   Web of Science ®Google Scholar
• Wynants L , Van CalsterB , CollinsGSet al. Prediction models for diagnosis and prognosis of COVID-19 infection: systematic review and critical appraisal. BMJ369(7), m1328 (2020).
   PubMedGoogle Scholar